FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Xavier Fabregat

Research Profile

Geographic Areas

Spain

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Physiology

Co-author Network

Publications

TOP 3
Joan Carles; Miguel Nogue; Josep M Sole; Palmira Foro; Montserrat Domenech; Marta Suarez; E Gallardo; Darío García; Ferrán Ferrer; Antoni Gelabert-Mas; Javier Gayo; Xavier Fabregat
Phase II study of vinorelbine and estramustine in combination with conformational radiotherapy for patients with high-risk prostate cancer.
Joan Carles; E Esteban; Miguel Angel Climent; Albert Font; Jose Luis Gonzalez-Larriba; A Berrocal; I Garcia-Ribas; X Marfa; Xavier Fabregat; Joan Albanell; Joaquim Bellmunt
Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer.
Joan Carles; Mariano Monzo; Marta Amat; Sonia Jansa; Rosa Artells; Alfons Navarro; Palmira Foro; Francesc Alameda; Angel Gayete; Bernat Gel; Maribel Miguel; Joan Albanell; Xavier Fabregat
Single-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with Stage I to II head-and-neck cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Xavier Fabregat (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Joan Carles; Miguel Nogue; Josep M Sole; Palmira Foro; Montserrat Domenech; Marta Suarez; E Gallardo; Darío García; Ferrán Ferrer; Antoni Gelabert-Mas; Javier Gayo; Xavier Fabregat
Phase II study of vinorelbine and estramustine in combination with conformational radiotherapy for patients with high-risk prostate cancer.
International journal of radiation oncology, biology, physics 2010;76(4):1085-91.
2007: Joan Carles; E Esteban; Miguel Angel Climent; Albert Font; Jose Luis Gonzalez-Larriba; A Berrocal; I Garcia-Ribas; X Marfa; Xavier Fabregat; Joan Albanell; Joaquim Bellmunt
Gemcitabine and oxaliplatin combination: a multicenter phase II trial in unfit patients with locally advanced or metastatic urothelial cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(8):1359-62.
2006: Joan Carles; Mariano Monzo; Marta Amat; Sonia Jansa; Rosa Artells; Alfons Navarro; Palmira Foro; Francesc Alameda; Angel Gayete; Bernat Gel; Maribel Miguel; Joan Albanell; Xavier Fabregat
Single-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with Stage I to II head-and-neck cancer.
International journal of radiation oncology, biology, physics 2006;66(4):1022-30.
2006: Joan Carles; Cristina Suárez; Carlos Mesía; Miquel Nogué; Albert Font; Montserrat Doménech; Marta Suárez; Ignasi Tusquets; Manuel Gallén; Joan Albanell; Xavier Fabregat
Feasiblity study of gemcitabine and cisplatin administered every two weeks in patients with advanced urothelial tumors and impaired renal function.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2006;8(10):755-7.
2006: Clara Montagut; Ignasi Tusquets; Berta Ferrer; Josep M Corominas; Beatriz Bellosillo; C Campas; Marta Suarez; Xavier Fabregat; Elias Campo; Pere Gascon; Sergi Serrano; Pedro L Fernandez; Ana Rovira; Joan Albanell
Activation of nuclear factor-kappa B is linked to resistance to neoadjuvant chemotherapy in breast cancer patients.
Endocrine-related cancer 2006;13(2):607-16.
2006: Cristina Corzo; Josep M Corominas; Ignasi Tusquets; Marta Salido; Meritxell Bellet; Xavier Fabregat; Sergi Serrano; Francesc Solé
The MYC oncogene in breast cancer progression: from benign epithelium to invasive carcinoma.
Cancer genetics and cytogenetics 2006;165(2):151-6.
2005: Beatriz Bellosillo; Ignasi Tusquets; Raquel Longarón; Anna Pérez-Lezaun; Meritxell Bellet; Xavier Fabregat; Sergi Serrano; Francesc Solé
Absence of CHEK2 mutations in Spanish families with hereditary breast cancer.
Cancer genetics and cytogenetics 2005;161(1):93-5.
2005: Miquel Porta; Xavier Fabregat; Núria Malats; Luisa Guarner; Alfredo Carrato; Ana de Miguel; Laura Ruiz; Manuel Jariod; Sergi Costafreda; Susanna Coll; Juan Alguacil; Josep M Corominas; Ricard Solà; Antonio Salas; Francisco X Real
Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2005;7(5):189-97.
2005: Marta Salido; Ignasi Tusquets; Josep M Corominas; Marta Suarez; Blanca Espinet; Cristina Corzo; Meritxell Bellet; Xavier Fabregat; Sergi Serrano; Francesc Solé
Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.
Breast cancer research : BCR 2005;7(2):R267-73.
2005: Cristina Corzo; Ignasi Tusquets; Marta Salido; Josep M Corominas; Meritxell Bellet; Marta Suarez; Teresa Baró; Xavier Fabregat; Sergi Serrano; Francesc Solé
Characterization of HER1 (c-erbB1) status in locally advanced breast cancer using fluorescence in situ hybridization and immunohistochemistry.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2005;26(1):25-30.
2004: Cristina Corzo; Ignasi Tusquets; Marta Suarez; Xavier Fabregat; Marta Salido; Francesc Solé; Josep M Corominas; Sergi Serrano
Intratumoral heterogeneity of HER2/neu and topoisomerase IIalpha in breast cancer: a case with clonal monosomy 17.
Cancer genetics and cytogenetics 2004;154(1):89-90.
2004: Joan Carles; Josep Lloreta; Marta Salido; Albert Font; Marta Suarez; Veronica Baena; Miquel Nogue; Montserrat Domenech; Xavier Fabregat
Her-2/neu expression in prostate cancer: a dynamic process?
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(14):4742-5.
1998: Miquel Porta; Núria Malats; E Morell; G Gomez; Manuel Gallén; Francesc Macià; Montserrat Casamitjana; Xavier Fabregat
Decreased survival of patients with lung cancer admitted to a teaching hospital through the emergency department in Barcelona, Spain.
Journal of epidemiology and community health 1998;52(2):137-8.
1998: Joan Carles; Montserrat Domenech; Antoni Gelabert-Mas; M Nogue; Josep Tabernero; Angels Arcusa; Inmaculada Guasch; A Miguel; J J Ballesteros; Xavier Fabregat
Phase II study of estramustine and vinorelbine in hormone-refractory prostate carcinoma patients.
Acta oncologica (Stockholm, Sweden) 1998;37(2):187-91.
1997: A Agudo; M G Esteve; C Pallarés; I Martínez-Ballarín; Xavier Fabregat; Núria Malats; I Machengs; A Badia; Carlos A González
Vegetable and fruit intake and the risk of lung cancer in women in Barcelona, Spain.
European journal of cancer (Oxford, England : 1990) 1997;33(8):1256-61.
1997: Manuel Gallén; J Pla; A Miguel; R Ibeas; Joan Carles; Xavier Fabregat
Anal carcinoma: a 14 year experience.
Revista española de enfermedades digestivas : organo oficial de la Sociedad Española de Patología Digestiva 1997;89(1):23-8.
1996: Albert Abad; C Grávalos; Albert Font; F Molina; M T Díaz-Puente; Xavier Fabregat; A Benavides; Miguel Martín
Phase II study of Mitonafide in advanced and relapsed colorectal cancer.
Investigational new drugs 1996;14(2):223-5.
1995: Albert Abad; P Garcia; C Gravalos; I Tusquets; Albert Font; G Perez; Hernán Cortés-Funes; Xavier Fabregat; Agustí Barnadas; Rafael Rosell
Sequential methotrexate, 5-fluorouracil (5-FU), and high dose leucovorin versus 5-FU and high dose leucovorin versus 5-FU alone for advanced colorectal cancer. A multi-institutional randomized trial.
Cancer 1995;75(6):1238-44.
1994: A Agudo; Agustí Barnadas; C Pallares; I Martinez; Xavier Fabregat; J Rosello; J Estape; J Planas; Carlos A Gonzalez
Lung cancer and cigarette smoking in women: a case-control study in Barcelona (Spain).
International journal of cancer. Journal international du cancer 1994;59(2):165-9.
1994: Josep Lloreta; C Vadell; Xavier Fabregat; Sergi Serrano
Fibrolamellar hepatic tumor with neurosecretory features and systemic deposition of AA amyloid.
Ultrastructural pathology 1994;18(1-2):287-92.
1992: M Doménech; I Tusquets; Xavier Fabregat; C Vadell; J M Corominas; Hernando Knobel
[Acquired immunodeficiency syndrome and T-cell non-Hodgkin's lymphoma].
Medicina clínica 1992;99(6):225-6.